N Brewer
Massey University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by N Brewer.
Clinical Transplantation | 2003
J Wight; Jim Chilcott; Michael Holmes; N Brewer
Abstract: Objective: To identify and prioritize key areas for further research in kidney preservation systems.
Journal of Womens Health | 2009
N Brewer; Neil Pearce; Mona Jeffreys; Paul White; Lis Ellison-Loschmann
OBJECTIVE To investigate ethnic, socioeconomic, and urban/rural differences in stage at diagnosis and cervical cancer survival in New Zealand. METHODS The study involved 1594 cervical cancer cases registered during 1994-2005. Cox regression was used to estimate adjusted cervical cancer mortality hazard ratios (HRs). RESULTS Māori and Pacific women had higher death rates than Other (predominantly European) women, with age and year of diagnosis adjusted HRs of 2.15 (95% CI 1.68-2.75) and 1.98 (95% CI 1.25-3.13), respectively, whereas Asian women had a lower (nonstatistically significant) risk (0.81, 95% CI 0.47-1.42). Adjustment for stage reduced the HR in Māori to 1.62 (95% CI 1.25-2.09), but there was little change for Pacific or Asian women. These patterns varied over time: for cases diagnosed during 1994-1997, the HR for Māori women was 2.34 (95% CI 1.68-3.27), which reduced to 1.83 (95% CI 1.29-2.60) when adjusted for stage; for cases diagnosed during 2002-2005, the corresponding estimates were 1.54 (95% CI 0.75-3.13) and 0.90 (95% CI 0.43-1.89). Socioeconomic status and urban/rural residence had only marginal effects. CONCLUSIONS There were major ethnic differences in cervical cancer survival in New Zealand that were only partly explained by stage at diagnosis. These patterns varied over time, with postdiagnostic factors playing an important role in the high Māori mortality rates in the 1990s, but in more recent years, the excess mortality in Māori women appeared to be almost entirely due to stage at diagnosis, indicating that ethnic differences in access to and uptake of screening and treatment of premalignant lesions may have been playing a major role.
Australian and New Zealand Journal of Public Health | 2012
N Brewer; Neil Pearce; Peter Day; Barry Borman
Objective: To investigate whether travel time or distance to the nearest general practitioner (GP) and/or cancer centre accounts for the ethnic differences in cervical cancer screening, stage at diagnosis and mortality in New Zealand (NZ).
BMJ | 2004
N Brewer
EDITOR—I agree with Vlassovs comments on the paper by del Giglio and Costa (previous letter).1 Research articles must be read with a critical eye, and it should not be assumed that high quality methods have been followed. To assume that the …
Health Technology Assessment | 2005
Matt Stevenson; M Lloyd Jones; E De Nigris; N Brewer; Sarah Davis; Jeremy E. Oakley
Health Technology Assessment | 2003
Sue Ward; Eva Kaltenthaler; J Cowan; N Brewer
Health Technology Assessment | 2003
J Wight; Jim Chilcott; Michael Holmes; N Brewer
Health Technology Assessment | 2004
Jonathan Karnon; J Peters; J Platt; Jim Chilcott; E. McGOOGAN; N Brewer
Health Technology Assessment | 2003
S Hummel; Anne Morgan; E. Currie; N Brewer
Diabetes Care | 2008
N Brewer; Craig Wright; Noémie Travier; Chris Cunningham; John Hornell; Neil Pearce; Mona Jeffreys